News | Contrast Media Injectors | September 02, 2020

Contrast Media Injectors Market Projected at $1.9 billion by 2025

the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector Systems (CT Injector, MRI Injector), Consumables (Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) - Global Forecast to 2025," published by MarketsandMarkets, the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025.

Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the market. However, the high cost of contrast media injectors and consumables and accessories is restraining the growth of the market to a certain extent.

The consumables segment accounted for the largest share of the contrast media injection market, by type, in 2019. Based on the product, the contrast media injectors market is segmented into injector systems, consumables and accessories. The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors. The consumables segment is segmented further into syringes, tubes, other consumables. In 2019, the consumables segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. These consumables need to be re-purchased for every new procedure, as opposed to instruments, thus driving its demand.

The interventional cardiology segment to register the highest CAGR in the market during the forecast period. Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. In 2019, the interventional cardiology segment had the highest growth rate of the market. The rising prevalence of CVD is driving the growth of this application segment.
The hospital segment will continue to dominate the contrast media injector end-user market during the forecast period. Based on end-user, the market is segmented into hospitals and diagnostic imaging centers. The hospital segment commanded the highest growth rate of the global market in 2019. The high growth rate of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals and the growing inclination of hospitals towards the automation and digitization of radiology patient workflow.

For more information: www.marketsandmarkets.com

Related Content

Advancements in medical digital technology, rise in prevalence of chronic diseases, development of IT infrastructure, and increase in healthcare expenditure fuel the growth of the global teleradiology market

Getty Images

News | Patient Engagement | September 02, 2020
September 2, 2020 — Allied Market Research published a report, titled, "...
Change Healthcare acquires industry standard for episode of care definitions used for value-based care plans
News | Radiology Business | August 26, 2020
August 26, 2020 — Change Healthcare announced it has acquired...
The above image shows a quantitative rCBV map, automatically generated within the Arterys platform

The above image shows a quantitative rCBV map, automatically generated within the Arterys platform.

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Imaging Biometrics, LLC, a subsidiar
Acquisition complements Hyland’s platform and rich product portfolio of automation and integration tools

Getty Images

News | Radiology Business | August 21, 2020
August 21, 2020 — Hyland, a leading content services provider, a
Change Healthcare announced the acquisition of Nucleus.io, a leader in the development of advanced, fully enabled, cloud-native imaging and workflow technology.
News | Enterprise Imaging | August 21, 2020
August 21, 2020 — Change Healthcare announced the acqui
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic.

Getty Images

News | Coronavirus (COVID-19) | August 19, 2020
August 19, 2020 — The...